A Prospective Feasibility Study to Evaluate the Safety and Performance of the Exhale(R) Drug-Eluting Stent System in Patients With Emphysema

Trial Profile

A Prospective Feasibility Study to Evaluate the Safety and Performance of the Exhale(R) Drug-Eluting Stent System in Patients With Emphysema

Completed
Phase of Trial: Phase II/III

Latest Information Update: 07 Dec 2015

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Emphysema
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Broncus Technologies
  • Most Recent Events

    • 22 May 2014 New trial record
    • 22 Jan 2008
    • 31 Oct 2006
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top